Aims Although aspirin treatment is useful in reducing ischaemic events in diabetic patients, recent studies suggest that it is less effective when compared with non-diabetics (ND). We sought to evaluate COX-1 sensitivity and thromboxane A2 (TxA2) production in type 1 (T1DM) and type 2 diabetic (T2DM) patients under chronic aspirin treatment, and also evaluate the association between thromboxane A2 (TxA2) production and markers of inflammation and metabolic control, such as high-sensitivity C-reactive protein, fasting blood glucose, and haemoglobin A1c (HbA1c). Methods and results Agonist-induced platelet aggregation (PA) and TxB2, a stable metabolite of TxA2, production, serum TxB2, and platelet COX-1 and COX-2 expression were studied in T2DM patients, T1DM patients, and high-risk ND subjects, all receiving a low dose of aspirin. TxB2 formation was studied in platelets treated in vitro with aspirin alone or with a COX-2 inhibitor (NS-398). PA, collagen-induced TxB2 production, and serum TxB2 were higher in T1DM and T2DM patients than in ND subjects. TxB2 production was reduced in diabetic patients by in vitro treatment with aspirin. COX-2 was expressed in all diabetic patients but only in 46% of ND patients. In diabetic patients significant correlations were observed between TxB2 production and both fasting plasma glucose and HbA1c. Conclusion COX-1 sensitivity and TxB2 production is similarly reduced in both T1DM and T2DM patients under chronic aspirin treatment. The association between TxB2 production and either fasting plasma glucose and HbA1c levels suggests that in diabetic patients hyperglycaemia is a determinant of the reduced platelet sensitivity to aspirin.

COX-1 sensitivity and thromboxane A(2) production in type 1 and type 2 diabetic patients under chronic aspirin treatment / Pulcinelli, FABIO MARIA; Biasucci, Lm; Riondino, Silvia; Giubilato, S; Leo, A; DI RENZO, Livia Maria; Trifirò, Elisabetta; Mattiello, Teresa; Pitocco, D; Liuzzo, G; Ghirlanda, G; Crea, F.. - In: EUROPEAN HEART JOURNAL. - ISSN 0195-668X. - STAMPA. - 30(10):(2009), pp. 1279-1286. [10.1093/eurheartj/ehp097]

COX-1 sensitivity and thromboxane A(2) production in type 1 and type 2 diabetic patients under chronic aspirin treatment

PULCINELLI, FABIO MARIA;RIONDINO, Silvia;DI RENZO, Livia Maria;TRIFIRÒ, Elisabetta;MATTIELLO, TERESA;
2009

Abstract

Aims Although aspirin treatment is useful in reducing ischaemic events in diabetic patients, recent studies suggest that it is less effective when compared with non-diabetics (ND). We sought to evaluate COX-1 sensitivity and thromboxane A2 (TxA2) production in type 1 (T1DM) and type 2 diabetic (T2DM) patients under chronic aspirin treatment, and also evaluate the association between thromboxane A2 (TxA2) production and markers of inflammation and metabolic control, such as high-sensitivity C-reactive protein, fasting blood glucose, and haemoglobin A1c (HbA1c). Methods and results Agonist-induced platelet aggregation (PA) and TxB2, a stable metabolite of TxA2, production, serum TxB2, and platelet COX-1 and COX-2 expression were studied in T2DM patients, T1DM patients, and high-risk ND subjects, all receiving a low dose of aspirin. TxB2 formation was studied in platelets treated in vitro with aspirin alone or with a COX-2 inhibitor (NS-398). PA, collagen-induced TxB2 production, and serum TxB2 were higher in T1DM and T2DM patients than in ND subjects. TxB2 production was reduced in diabetic patients by in vitro treatment with aspirin. COX-2 was expressed in all diabetic patients but only in 46% of ND patients. In diabetic patients significant correlations were observed between TxB2 production and both fasting plasma glucose and HbA1c. Conclusion COX-1 sensitivity and TxB2 production is similarly reduced in both T1DM and T2DM patients under chronic aspirin treatment. The association between TxB2 production and either fasting plasma glucose and HbA1c levels suggests that in diabetic patients hyperglycaemia is a determinant of the reduced platelet sensitivity to aspirin.
2009
Platelets; Aspirin; Diabetes
01 Pubblicazione su rivista::01a Articolo in rivista
COX-1 sensitivity and thromboxane A(2) production in type 1 and type 2 diabetic patients under chronic aspirin treatment / Pulcinelli, FABIO MARIA; Biasucci, Lm; Riondino, Silvia; Giubilato, S; Leo, A; DI RENZO, Livia Maria; Trifirò, Elisabetta; Mattiello, Teresa; Pitocco, D; Liuzzo, G; Ghirlanda, G; Crea, F.. - In: EUROPEAN HEART JOURNAL. - ISSN 0195-668X. - STAMPA. - 30(10):(2009), pp. 1279-1286. [10.1093/eurheartj/ehp097]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/363999
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 13
  • Scopus 76
  • ???jsp.display-item.citation.isi??? 66
social impact